ChEMBL logo

ChEMBL

spacer
ChEMBL Statistics
  Loading Statistics...
spacer

Compound Report Card

Compound Name and Classification

Compound ID CHEMBL1384
CHEMBL1384
Compound Name KANAMYCIN
ChEMBL Synonyms KANTREX | KANAMYCIN MONOSULFATE | KLEBCIL | KANAMYCIN SULFATE | KANAMYCIN
Max Phase 4 (Approved)
Trade Names KANAMYCIN SULFATE | KANAMYCIN | KLEBCIL | KANTREX
Molecular Formula C18H36N4O11

Additional synonyms for CHEMBL1384 found using NCI Chemical Identifier Resolver

Compound Representations

Molfile Download MolFile
Canonical SMILES NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H ...
Download SMILES
Standard InChI InChI=1S/C18H36N4O11/c19-2-6-10(25)12(27)13(28)18(30-6)33-16 ...
Download InChI
Standard InChI Key SBUJHOSQTJFQJX-NOAMYHISSA-N

Sources

  • British National Formulary
  • DrugMatrix
  • HeCaToS Compounds
  • Orange Book
  • PubChem BioAssays
  • Scientific Literature
  • USP Dictionary of USAN and International Drug Names
  • WHO Anatomical Therapeutic Chemical Classification

Alternate Forms of Compound in ChEMBL


CHEMBL1384

Molecule Features

CHEMBL1384 compound icon
Drug Type:Natural Product-derived Rule of Five:N First In Class:N Chirality:Single Stereoisomer Prodrug:N Oral:Y Parenteral:Y Topical:N Black Box:N Availability Type:Prescription-only

Mechanism of Action

Mechanism of Action ChEMBL Target References
Bacterial 70S ribosome inhibitor Bacterial 70S ribosome PubMed

Indications

MESH Heading MESH ID EFO ID EFO Term Max phase for indication References
TuberculosisD014376Orphanet:3389Tuberculosis3ClinicalTrials
Colorectal NeoplasmsD015179EFO:0004142colorectal neoplasm3ClinicalTrials
Tuberculosis, Multidrug-ResistantD018088EFO:0007381multidrug-resistant tuberculosis2ClinicalTrials
OsteomyelitisD010019EFO:0003102osteomyelitis0ClinicalTrials
ClinicalTrials

Clinical Data

ClinicalTrials.gov KANAMYCIN
The Cochrane Collaboration KANAMYCIN

Compound Bioactivity Summary

Compound Assay Summary

Compound Target Summary

Calculated Compound Parent Properties

Mol. Weight Mol. Weight Monoisotopic ALogP #Rotatable Bonds Polar Surface Area Molecular Species
484.5 484.2381 -7.29 6 282.61 BASE


HBA HBD #Ro5 Violations HBA (Lipinski) HBD (Lipinski) #Ro5 Violations (Lipinski)
15 11 2 15 15 2


ACD Acidic pKa ACD Basic pKa ACD LogP ACD LogD pH7.4 Aromatic Rings Heavy Atoms QED Weighted
12.94 9.52 -4.6 -8.86 0 33 0.17

Structural Alerts

There are 3 structural alerts for CHEMBL1384. To view alerts please click here.

Compound Cross References

ATC J - ANTIINFECTIVES FOR SYSTEMIC USE
J01 - ANTIBACTERIALS FOR SYSTEMIC USE
J01G - AMINOGLYCOSIDE ANTIBACTERIALS
J01GB - Other aminoglycosides
J01GB04 - kanamycin

S - SENSORY ORGANS
S01 - OPHTHALMOLOGICALS
S01A - ANTIINFECTIVES
S01AA - Antibiotics
S01AA24 - kanamycin

A - ALIMENTARY TRACT AND METABOLISM
A07 - ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
A07A - INTESTINAL ANTIINFECTIVES
A07AA - Antibiotics
A07AA08 - kanamycin

ChemSpider ChemSpider:SBUJHOSQTJFQJX-NOAMYHISSA-N
Wikipedia Kanamycin

UniChem Cross References

View the UniChem Connectivity matches for CHEMBL1384



ACToR 11025-65-3 8063-07-8
Brenda 5165 789
ChEBI 17630
DrugBank DB01172
DrugCentral 1519
eMolecules 26751879 36728492
EPA CompTox Dashboard DTXSID3023184
FDA SRS EQK9Q303C5
Human Metabolome Database HMDB0015303
IBM Patent System 756AD92A3E0B55A0C80CB2DCBC94E0C4
KEGG Ligand C01822
LINCS LSM-5261
Metabolights MTBLC17630
MolPort MolPort-006-167-728
Nikkaji J4.492J
PDBe KAN
PharmGKB PA450137
PubChem 6032
PubChem: Thomson Pharma 16090268 14785807
SureChEMBL SCHEMBL2735
ZINC ZINC000008214590

UniChem REST Service Call:
https://www.ebi.ac.uk/unichem/rest/verbose_inchikey/SBUJHOSQTJFQJX-NOAMYHISSA-N spacer
spacer